Long-term effects of tiagabine monotherapy on cognition and mood in adult patients with chronic partial epilepsy

Epilepsy and Behavior

Volumn 8, Issue 4, 2006, Pages 750-755

  Äikiä, Marja ^a   Jutila, Leena ^a   Salmenperä, Tuuli ^a   Mervaala, Esa ^a,b   Kälviäinen, Reetta ^a,b  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Antiepileptic drug; Cognition; Epilepsy; Mood; Tiagabine

Indexed keywords

CARBAMAZEPINE; CLOBAZAM; CLONAZEPAM; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; TIAGABINE; VALPROIC ACID; VIGABATRIN;

ADULT; ARTICLE; ATTENTION; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITIVE DEFECT; DOUBLE BLIND PROCEDURE; DRUG DOSE REGIMEN; DRUG EFFECT; FEMALE; FOCAL EPILEPSY; FOLLOW UP; HUMAN; INTELLIGENCE; LEARNING; LONG TERM CARE; MALE; MEMORY; MENTAL HEALTH; MONOTHERAPY; MOOD DISORDER; NEUROPSYCHOLOGICAL TEST; OPEN STUDY; SEIZURE;

ADOLESCENT; ADULT; AFFECT; AGED; AGED, 80 AND OVER; ANTICONVULSANTS; CHRONIC DISEASE; COGNITION; DOUBLE-BLIND METHOD; EPILEPSIES, PARTIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; NIPECOTIC ACIDS;

EID: 33646494849     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2006.03.007     Document Type: Article

References (27)

1. Meador K.J. Cognitive outcomes and predictive factors in epilepsy. Neurology 58 8, Suppl. 5 (2002) S21-S26
2. Ortinski P., and Meador K.J. Cognitive side effects of antiepileptic drugs. Epilepsy Behav 5 Suppl. 1 (2004) S60-S65
3. Motamedi G., and Meador K. Epilepsy and cognition. Epilepsy Behav 4 Suppl. 2 (2003) S25-S38
4. Vermeulen J., and Aldenkamp A.P. Cognitive side-effects of chronic antiepileptic drug treatment: a review of 25 years of research. Epilepsy Res 22 (1995) 65-95
5. Fisher R.S. Epilepsy from the patient's perspective: review of results of a community-based survey. Epilepsy Behav 1 (2000) S9-S14
6. Aldenkamp A.P. Effects of antiepileptic drugs on cognition. Epilepsia 42 Suppl. 1 (2001) 46-49 discussion
7. Kalviainen R. Cognitive effects of GABAergic antiepileptic drugs. Electroencephalogr Clin Neurophysiol Suppl 50 (1999) 458-464
8. Reijs R., Aldenkamp A.P., and de Krom M. Mood effects of antiepileptic drugs. Epilepsy Behav 5 (2004) S66-S76
9. Borden L.A., Murali Dhar T.G., Smith K.E., et al. Tiagabine, SK&F 89976-A, CI-966, and NNC-711 are selective for the cloned GABA transporter GAT-1. Eur J Pharmacol 269 (1994) 219-224
10. Fink-Jensen A., Judge M.E., Hansen J.B., et al. The gamma-aminobutyric acid (GABA) uptake inhibitor, tiagabine, increases extracellular brain levels of GABA in awake rats. Eur J Pharmacol 220 (1992) 197-201
11. Dodrill C.B., Arnett J.L., Shu V., et al. Effects of tiagabine monotherapy on abilities, adjustment, and mood. Epilepsia 39 (1998) 33-42
12. Dodrill C.B., Arnett J.L., Sommerville K.W., and Shu V. Cognitive and quality of life effects of differing dosages of tiagabine in epilepsy. Neurology 48 (1997) 1025-1031
13. Kälviäinen R., Äikiä M., Mervaala E., et al. Long-term cognitive and EEG effects of tiagabine in drug-resistant partial epilepsy. Epilepsy Res 25 (1996) 291-297
14. Wechsler D. Wechsler Adult Intelligence Scale-Revised (1981), Psychological Corp., San Antonio, TX
15. Lezak M.D. Neuropsychological assessment. 3rd ed. (1995), Oxford Univ. Press, New York
16. Wechsler D.A. A standardized memory scale for clinical use. J Psychol 19 (1945) 87-95
17. Allison R.S. Perserveration as a sign of diffuse and focal brain damage. Br Med J 2 (1966) 1027-1032
18. Alpherts W.C.J., and Aldenkamp A.P. Computerized neuropsychological assessment of cognitive functioning in children with epilepsy. Epilepsia 31 (1990) S35-S40
19. McNair D.M., Lorr M., and Droppleman L.M. Profile of Mood States: manual (1981), Educational and Industrial Testing Service, San Diego
20. Sveinbjornsdottir S., Sander J.W., Patsalos P.N., et al. Neuropsychological effects of tiagabine, a potential new antiepileptic drug. Seizure 3 (1994) 29-35
21. Fritz N., Glogau S., Hoffmann J., et al. Efficacy and cognitive side effects of tiagabine and topiramate in patients with epilepsy. Epilepsy Behav 6 (2005) 373-381
22. Leach J.P., Girvan J., Paul A., and Brodie M.J. Gabapentin and cognition: a double blind, dose ranging, placebo controlled study in refractory epilepsy. J Neurol Neurosurg Psychiatry 62 (1997) 372-376
23. Meador K.J., Loring D.W., Ray P.G., et al. Differential cognitive and behavioral effects of carbamazepine and lamotrigine. Neurology 56 (2001) 1177-1182
24. Äikiä M., Kälviäinen R., Sivenius J., et al. Cognitive effects of oxcarbazepine and phenytoin monotherapy in newly diagnosed epilepsy: one year follow-up. Epilepsy Res 11 (1992) 199-203
25. Kälviäinen R., Äikiä M., Saukkonen A.M., et al. Vigabatrin vs carbamazepine monotherapy in patients with newly diagnosed epilepsy: a randomized, controlled study. Arch Neurol 52 (1995) 989-996
26. Ketter T.A., Post R.M., and Theodore W.H. Positive and negative psychiatric effects of antiepileptic drugs in patients with seizure disorders. Epilepsia 53 5, Suppl. 2 (1999) S53-S67
27. Committee on Drugs, American Academy of Pediatrics. Behavioral and cognitive effects of anticonvulsant therapy. Pediatrics 1985;76:644-7.